Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

Investor Relations

FINANCIAL INFORMATION

Financial Information

Here you will find a summary of Stemline Therapeutics's latest financial information.

Form	Filing date	View
10-Q	May 14, 2013	0001104659-13-041401.pdf View HTML
10-Q/A	Jun 12, 2013	0001104659-13-048660.pdf EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Form	Filing date	View
10-K	Apr 01, 2013	0001104659-13-026212.pdf View HTML

Form	Filing date	View
PRE 14A	Apr 19, 2013	0001047469-13-004617.pdf View HTML